Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset
Understanding and mitigating SARS-CoV-2 transmission hinges on antibody and viral RNA data that inform exposure and shedding, but extensive variation in assays, study group demographics and laboratory protocols across published studies confounds inference of true biological patterns. Our meta-analys...
Main Authors: | Benny Borremans, Amandine Gamble, KC Prager, Sarah K Helman, Abby M McClain, Caitlin Cox, Van Savage, James O Lloyd-Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2020-09-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/60122 |
Similar Items
-
HMM modelling for the spread of the SARS–CoV–2
by: Beneš, Martin
Published: (2021) -
How Should We Quantify Uncertainty in Statistical Inference?
by: Subhash R. Lele
Published: (2020-03-01) -
Model for Quantifying the Quality of Secure Service
by: Paul M. Simon, et al.
Published: (2021-05-01) -
Estimating the global reduction in transmission and rise in detection capacity of the novel coronavirus SARS-CoV-2 in early 2020
by: Antoine Belloir, et al.
Published: (2021-06-01) -
Taiwan Earthquake Occurrence Probability Estimation from Regional Source Model Since 1900
by: Kuo-Liang Wen, et al.
Published: (2014-01-01)